Bone marrow transplantation for aplastic anemia and acute leukemia at Huddinge Hospital

Scand J Urol Nephrol Suppl. 1981:64:238-45.

Abstract

Eight patients with aplastic anemia were transplanted with marrow from HLA-identical donors. Two patient rejected their grafts and died while 5 patients (71%) show no ill effects 3 months, 10 months, and more than 1, 2 and 4 years after the transplantation. Three of the patients who received unirradiated donor buffy coat after transplantation developed chronic graft-versus-host disease (GVHD) which, however, resolved following treatment with Prednisolone and Azathioprine. One patient with end-stage acute myeloid leukemia, who was transplanted with marrow from an identical twin, died 6 days after the transplantation of bleedings and sepsis. Eight patients with acute non-lymphoblastic leukemia (ANL) were transplanted, while in remission, with marrow from HLA-identical siblings. One patient died of interstitial pneumonia 3 months after transplantation, while another patient recovered from GVHD of the gut at 5 months after the transplantation. Seven out of 8 patients with ANL (88%) are home and well between 2 and 12 months after the transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Anemia, Aplastic / epidemiology
  • Anemia, Aplastic / mortality
  • Anemia, Aplastic / therapy*
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Female
  • Graft Rejection
  • Graft vs Host Reaction / drug effects
  • Humans
  • Leukemia / epidemiology
  • Leukemia / therapy*
  • Leukemia, Myeloid, Acute / epidemiology
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Sweden

Substances

  • Prednisolone